Related Experiment Video
Updated: Jul 14, 2026

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
[Immunoproteomics of Helicobacter pylori--strategy for improvement of diagnostic tests and vaccine development]
Paula Roszczenko1, Elzbieta Katarzyna Jagusztyn-Krynicka
1Zakład Genetyki Bakterii, Instytut biologii, Wydział Biologii, Uniwersytet Warszawski, Warszawa.
Abstract:
Helicobacter pylori, Gram-negative spiral-shaped bacteria, member of epsilon-Proteobacteria, colonizes the gastric mucosa of humans. H. pylori has been identified as the causative agent of chronic inflammation, chronic gastritis and peptic ulceration and is considered a risk factor for the development of mucosa-associated lymphoid tissue lymphoma and adenocarcinoma of the stomach. Although more than 50% of human population is infected with H. pylori only a subset develops disease. The completion of two H. pylori genome sequences revealed the enormous strain heterogeneity and permitted comparative proteome analysis. Immunoproteomics, a novel strategy combining standard proteomics with immunological screening, is currently method of choice for identification of new antigens of diagnostic and protective values. Highly specific antigens will be used as biomarkers of different pathology induced by H. pylori infection whereas novel highly immunogenic, conserved, abundant and surface-located proteins will facilitate efficient anti-Helicobacter vaccine construction.
More Related Videos
03:33Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology